SALT LAKE CITY, Jan. 10, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its financial results for its second fiscal quarter ended December 31, 2010, at the close of market on Thursday, January 27, 2011.
The Company will host a conference call on Thursday, January 27, at 4:30 p.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; and Mark C. Capone, President of Myriad Genetic Laboratories, Inc.
To participate on the call, callers may dial (800) 954-1053 or (212) 231-2915 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21507216.
The conference call also will be available to interested parties through a live audio Internet broadcast at .
A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8284 or (402) 977-9140, and entering the reservation number 21507216.
Myriad Genetics, Inc. is a leading molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products. Myriad's news and other information are available on the Company's Web site at . MYGN-F
The Myriad Genetics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6336
CONTACT: Rebecca Chambers Director, Investor Relations (801) 584-1143 rchamber@myriad.com